Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment. | Int J Mol Sci | 2023 | 37175399 | PubTator, text mining | PubMed |
| Fluorescence resonance energy transfer (FRET) spatiotemporal mapping of atypical P38 reveals an endosomal and cytosolic spatial bias. | Sci Rep | 2023 | 37156828 | PubTator, text mining | PubMed |
| Potential Biomarkers for Parkinson Disease from Functional Enrichment and Bioinformatic Analysis of Global Gene Expression Patterns of Blood and Substantia Nigra Tissues. | Bioinform Biol Insights | 2023 | 37153842 | PubTator, text mining | PubMed |
The mTOR inhibitor rapamycin suppresses trigeminal neuropathic pain and p-MKK4/p-p38 mitogen-activated protein kinase-mediated microglial activation in the trigeminal nucleus caudalis of mice with infraorbital nerve injury. | Front Mol Neurosci | 2023 | 37122619 | PubTator, text mining | PubMed |
| The genomic landscape of familial glioma. | Sci Adv | 2023 | 37115922 | PubTator, text mining | PubMed |
| Integrated Covalent Drug Design Workflow Using Site Identification by Ligand Competitive Saturation. | J Chem Theory Comput | 2023 | 37115781 | PubTator, text mining | PubMed |
| New Insights into Pathophysiology and New Risk Factors for ACS. | J Clin Med | 2023 | 37109221 | PubTator, text mining | PubMed |
| MKK4 Inhibitors-Recent Development Status and Therapeutic Potential. | Int J Mol Sci | 2023 | 37108658 | PubTator, text mining | PubMed |
| Potential of resveratrol in the treatment of interstitial lung disease. | Front Pharmacol | 2023 | 37089962 | PubTator, text mining | PubMed |
| FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling. | J Exp Clin Cancer Res | 2023 | 37085881 | PubTator, text mining | PubMed |
| Transcriptomic responses of bat cells to European bat lyssavirus 1 infection under conditions simulating euthermia and hibernation. | BMC Immunol | 2023 | 37085747 | PubTator, text mining | PubMed |
| Newly discovered mechanisms that mediate tumorigenesis and tumour progression: circRNA-encoded proteins. | J Cell Mol Med | 2023 | 37070530 | PubTator, text mining | PubMed |
| Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent. | Int J Mol Sci | 2023 | 37047688 | PubTator, text mining | PubMed |
| Integrating AI/ML Models for Patient Stratification Leveraging Omics Dataset and Clinical Biomarkers from COVID-19 Patients: A Promising Approach to Personalized Medicine. | Int J Mol Sci | 2023 | 37047222 | PubTator, text mining | PubMed |
| The ubiquitination status of the glucagon receptor determines signal bias. | J Biol Chem | 2023 | 37037304 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Involvement of matrix metalloproteinase 1 and urokinase-type plasminogen activator in the PKCα-p38 MAPK pathway-mediated progression of human liver cancer cells. | Drug Dev Res | 2023 | 37005497 | PubTator, text mining | PubMed |
| Diverse heterochromatin states restricting cell identity and reprogramming. | Trends Biochem Sci | 2023 | 36990958 | PubTator, text mining | PubMed |
| Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways. | Int J Mol Sci | 2023 | 36982421 | PubTator, text mining | PubMed |
| Computational and Functional Analysis of Structural Features in the ZAKα Kinase. | Cells | 2023 | 36980309 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=9